Extended‐Spectrum Beta‐Lactamase (ESBL)‐Producing E. coli in Livestock and Free‐Roaming Wildlife: A Combined Phenotyping—Whole‐Genome Sequencing One Health Approach
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/9907660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 05.08.2026. Verfasst von Sheena Conforti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf 8600, Switzerland. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Escherichia coli Infections, Animals, Wild. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Foundation for medical-biological Research, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universität Bern.
Abstract (Originalsprache)
Antimicrobial resistance (AMR) in Enterobacterales, particularly extended‐spectrum beta‐lactamase‐producing Escherichia coli (ESBL‐Ec), poses a significant public health concern. Widespread antimicrobial use exerts selection pressure, driving the persistence and spread of resistant bacteria in diverse environments. While ESBL‐Ec is well‐documented in clinical and agricultural settings, its presence in animal reservoirs remains poorly understood. This study assessed the prevalence, AMR profiles, and genetic diversity of ESBL‐Ec in Swiss dairy cattle and wildlife. Between 2021 and 2023, 775 samples were analyzed, including rectal swab samples from dairy cows ( n = 475) and fecal or cloacal swab samples from wildlife ( n = 300). ESBL‐Ec was detected in 3/475 (0.6%, 95% confidence interval [CI] 0.2%–1.8%) of dairy cattle and 15/300 (5%, 95% CI 3.1%–8.1%) wildlife samples, with higher prevalence in birds (6/99, 6.1%, 95% CI 2.8%–12.6%) than mammals (9/200, 4.5%, 95% CI 2.4%–8.3%). Whole‐genome sequencing (WGS) of 54 ESBL‐Ec isolates identified 28 sequence types (STs) with no overlap between livestock and wildlife, suggesting distinct evolutionary trajectories. Phenotypic testing revealed resistance beyond beta‐lactams, notably against aminoglycosides, tetracyclines, and sulfonamides, whereas all isolates remained susceptible to tigecycline and meropenem. Multidrug resistance (MDR) was prevalent (89%), with bla TEM-1 (in dairy cattle), bla CTX-M55 and bla TEM-176 (in red foxes) widely distributed across Switzerland. Clonal plasmids (IncFIB, IncX1) were detected in both wildlife and dairy cattle, and some animals harbored multiple ESBL‐Ec strains. Despite the low prevalence of plasmids, spatial clustering indicated local persistence in both livestock and wildlife, highlighting potential transmission. The observed presence of clinically relevant ESBL‐Ec in wildlife highlights the need for a One Health approach to tackle the dangers of AMR. Our findings contribute to AMR surveillance by providing baseline data on ESBL‐Ec animal reservoirs and informing the design of strategies to mitigate its environmental spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf 8600, Switzerland.
- Institute of Ecology and Evolution, University of Bern, Bern 3012, Switzerland, unibe.ch.
- Swiss Institute of Bioinformatics, Lausanne 1015, Switzerland, isb-sib.ch.
- Clinic for Ruminants, Vetsuisse-Faculty, University of Bern, Bern 3012, Switzerland, unibe.ch.
- Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern 3010, Switzerland, unibe.ch.
- Maurice Müller Laboratories, Department for Biomedical Research, University of Bern, Bern 3008, Switzerland, unibe.ch.
ORCID-Profile: Sheena Conforti, Adamandia Kapopoulou, Claudia Bank, Belinda Köchle, Bahtiyar Yilmaz, Jens Becker
Förderung
- Novartis Foundation for medical-biological Research
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Bern
- Consortium of Swiss Academic Libraries
Zitieren
APA
Conforti, S., Kapopoulou, A., Bank, C., Köchle, B., Yilmaz, B., & Becker, J. (2026). Extended‐Spectrum Beta‐Lactamase (ESBL)‐Producing E. coli in Livestock and Free‐Roaming Wildlife: A Combined Phenotyping—Whole‐Genome Sequencing One Health Approach. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/9907660
Vancouver
Conforti S, Kapopoulou A, Bank C, Köchle B, Yilmaz B, Becker J. Extended‐Spectrum Beta‐Lactamase (ESBL)‐Producing E. coli in Livestock and Free‐Roaming Wildlife: A Combined Phenotyping—Whole‐Genome Sequencing One Health Approach. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/9907660
BibTeX
@article{Conforti2026,
author = {Conforti, Sheena and Kapopoulou, Adamandia and Bank, Claudia and Köchle, Belinda and Yilmaz, Bahtiyar and Becker, Jens},
title = {Extended‐Spectrum Beta‐Lactamase (ESBL)‐Producing E. coli in Livestock and Free‐Roaming Wildlife: A Combined Phenotyping—Whole‐Genome Sequencing One Health Approach},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/9907660}
}
EUVIMED